Edwards Lifesciences Corporation (BMV:EW)
Mexico · Delayed Price · Currency is MXN 1,372.00
0.00 (0.00%)
At close: Oct 10, 2025
Edwards Lifesciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Net Income | 4,142 | 4,170 | 1,399 | 1,522 | 1,503 | 823.4 | Upgrade |
Depreciation & Amortization | 151.8 | 155.2 | 144.9 | 139.6 | 134.8 | 107.2 | Upgrade |
Stock-Based Compensation | 151.5 | 162.3 | 139.4 | 126.8 | 109.3 | 92.6 | Upgrade |
Other Adjustments | -216.8 | -3,686 | -261.6 | -148.7 | -160.4 | -11.1 | Upgrade |
Change in Receivables | 84.6 | 121.2 | -141.2 | -84.1 | -91.1 | 41.9 | Upgrade |
Changes in Inventories | -50.9 | -256.1 | -289 | -213.4 | 19 | -120.6 | Upgrade |
Changes in Accounts Payable | 27.1 | 89.5 | 146 | -21.4 | 195.2 | -84.5 | Upgrade |
Changes in Accrued Expenses | -74.2 | -36.8 | -33 | -45 | -29.2 | 270.5 | Upgrade |
Changes in Income Taxes Payable | -5.9 | -186.7 | -5.8 | -5.6 | 62 | -52.9 | Upgrade |
Changes in Other Operating Activities | -60.9 | 9.6 | -203.3 | -51.9 | -10.6 | -12.2 | Upgrade |
Operating Cash Flow | 794.9 | 542.3 | 895.8 | 1,218 | 1,732 | 1,054 | Upgrade |
Operating Cash Flow Growth | -8.22% | -39.46% | -26.46% | -29.67% | 64.29% | -10.87% | Upgrade |
Capital Expenditures | -207 | -252.4 | -253 | -244.6 | -325.8 | -407 | Upgrade |
Purchases of Intangible Assets | - | -30 | -13.3 | -20.2 | -4 | -0.3 | Upgrade |
Purchases of Investments | -2,208 | -945.8 | -75.5 | -669.3 | -1,879 | -851.7 | Upgrade |
Proceeds from Sale of Investments | 1,916 | 857.6 | 715.8 | 1,359 | 529.2 | 777 | Upgrade |
Payments for Business Acquisitions | - | -1,062 | -95.2 | - | - | - | Upgrade |
Proceeds from Business Divestments | - | 3,927 | - | - | - | - | Upgrade |
Other Investing Activities | -240 | -182.1 | -105 | -172.7 | -42.6 | -49.1 | Upgrade |
Investing Cash Flow | 2,038 | 2,313 | 173.8 | 252.3 | -1,723 | -531.1 | Upgrade |
Long-Term Debt Issued | - | - | - | - | 5.2 | 16.2 | Upgrade |
Long-Term Debt Repaid | - | - | - | - | -7 | -17 | Upgrade |
Net Long-Term Debt Issued (Repaid) | - | - | - | - | -1.8 | -0.8 | Upgrade |
Issuance of Common Stock | 170.2 | 179.5 | 169.9 | 146.4 | 158.6 | 140.5 | Upgrade |
Repurchase of Common Stock | -1,265 | -1,159 | -879.6 | -1,727 | -512.8 | -625.4 | Upgrade |
Net Common Stock Issued (Repurchased) | -1,095 | -979.9 | -709.7 | -1,581 | -354.2 | -484.9 | Upgrade |
Other Financing Activities | -8.4 | -3.1 | -1.3 | -3.8 | -0.3 | -1.2 | Upgrade |
Financing Cash Flow | -1,153 | -983 | -711 | -1,585 | -356.3 | -486.9 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -47.8 | 38.6 | 16.8 | 19.2 | 13.9 | -20.5 | Upgrade |
Net Cash Flow | 1,632 | 1,911 | 375.4 | -94.8 | -332.8 | 15.8 | Upgrade |
Beginning Cash & Cash Equivalents | 1,658 | 1,148 | 772.6 | 867.4 | 1,200 | 1,184 | Upgrade |
Ending Cash & Cash Equivalents | 3,290 | 3,059 | 1,148 | 772.6 | 867.4 | 1,200 | Upgrade |
Free Cash Flow | 587.9 | 289.9 | 642.8 | 973.6 | 1,406 | 647.3 | Upgrade |
Free Cash Flow Growth | 102.79% | -54.90% | -33.98% | -30.77% | 117.26% | -30.29% | Upgrade |
FCF Margin | 10.34% | 5.33% | 12.83% | 21.81% | 26.88% | 14.76% | Upgrade |
Free Cash Flow Per Share | 0.99 | 0.48 | 1.05 | 1.56 | 2.23 | 1.02 | Upgrade |
Levered Free Cash Flow | 3,928 | 3,697 | 909.2 | 1,080 | 1,547 | 523.1 | Upgrade |
Unlevered Free Cash Flow | 956.9 | 764.95 | 670.35 | 863.31 | 1,538 | 506.74 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.